Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

74
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
74
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

733
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
733
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

107
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
107
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

79
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
79
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

52
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
52
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

90
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
90

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring whole-body inert gas uptake and washout during submersion.

Diving and hyperbaric medicine·2026
Same author

Learning Covariate Relations in Disease Progression Models Using Symbolic Neural Networks.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Discrete-time neural Markov models.

BMC medical research methodology·2026
Same author

Rifampicin concentrations throughout the entire treatment duration of active tuberculosis; impact of sex and body mass index.

The Journal of antimicrobial chemotherapy·2025
Same author

Concentration-QT modeling demonstrates that the selective mineralocorticoid receptor modulator, balcinrenone (AZD9977), does not prolong QT interval.

CPT: pharmacometrics & systems pharmacology·2024
Same author

Ex Vivo Working Porcine Heart Model.

Methods in molecular biology (Clifton, N.J.)·2024

Related Experiment Video

Updated: Jul 12, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.4K

Learning pharmacometric covariate model structures with symbolic regression networks.

Ylva Wahlquist1, Jesper Sundell2, Kristian Soltesz2

  • 1Department of Automatic Control, Lund University, P.O. Box 118, 221 00, Lund, Sweden. ylva.wahlquist@control.lth.se.

Journal of Pharmacokinetics and Pharmacodynamics
|October 21, 2023
PubMed
Summary

This study introduces a new symbolic regression method for automatically identifying covariate model structures in pharmacological data. The approach efficiently optimizes parameters and selects fewer covariates than current methods, improving model fit.

Keywords:
Covariate modelingNeural networksPharmacokineticsPharmacometricsSymbolic regression

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K

Related Experiment Videos

Last Updated: Jul 12, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.4K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K

Area of Science:

  • Pharmacometrics
  • Computational Biology
  • Machine Learning

Background:

  • Identifying covariate model structures in pharmacological data is complex and lacks automated tools.
  • Current methods often require manual intervention and may lead to overly complex models.
  • Neural networks offer potential but lack interpretability and generalizability.

Purpose of the Study:

  • To develop a novel methodology for simultaneous covariate model structure selection and parameter optimization.
  • To create a human-readable and generalizable model for pharmacokinetic data analysis.
  • To overcome limitations of existing iterative and manual approaches.

Main Methods:

  • Symbolic regression framed as a smooth optimization problem.
  • Utilizing back-propagation with efficient gradient computations for model training.
  • Application to a large clinical pharmacokinetic dataset for propofol.

Main Results:

  • The proposed methodology successfully identified a covariate model structure and optimized parameters.
  • The resulting model demonstrated a slightly improved fit compared to a state-of-the-art model.
  • The new model required significantly fewer covariates, enhancing interpretability and reducing complexity.

Conclusions:

  • The novel symbolic regression approach enables efficient and automated covariate model selection in pharmacometrics.
  • This method offers a more interpretable and parsimonious alternative to existing techniques.
  • The findings suggest a significant advancement in analyzing complex pharmacological data.